Skip to product search
DISCOUNT ON

Kerendia 20 Mg Tablet (10 Tab + 4 Free Tab)

Finerenone (20mg)

14 TABLETSProduct code 243975

YOUR PURCHASE PRICE

4 in stock
₹1,053.93MRP ₹1,401.5024.8% off

Inclusive of all taxes

Available batch

1 offer
Delivery from your selected hubPCMC

Sign in to order for your pharmacy.

Product information

Manufacturer
Bayer Zydus Pharma Pvt. Ltd.
Category
Allopathy
Composition
Finerenone (20mg)
Packaging
14 TABLETS
Box / case pack
1 / —
Description

KERENDIA 20 MG TABLET is a prescription medicine manufactured by BAYER ZYDUS PHARMA PVT. LTD. that contains the active ingredient finerenone. It is available as film-coated tablets, with the 20 mg tablet being yellow, oblong, and marked "FI" on one side and "20" on the other.

Composition

  • Active Ingredient: Finerenone 20 mg.
  • Inactive Ingredients: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, magnesium stearate, and sodium lauryl sulfate. The film coating contains hypromellose, titanium dioxide, talc, and ferric oxide yellow.

Uses

KERENDIA is indicated for adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) to reduce the risk of:

  • Sustained decline in estimated glomerular filtration rate (eGFR).
  • End-stage kidney disease.
  • Cardiovascular death.
  • Non-fatal myocardial infarction (heart attack).
  • Hospitalization for heart failure.

It works as a non-steroidal mineralocorticoid receptor antagonist (MRA), blocking the overactivation of mineralocorticoid receptors that can contribute to inflammation and fibrosis in the kidneys and heart.

Dosage and Administration

  • Typical Dosage: The recommended target dose is 20 mg once daily. The starting dose depends on the patient's kidney function (eGFR).
    • For eGFR ≥ 60 mL/min/1.73 m², the initial dose is 20 mg once daily.
    • For eGFR 25 to < 60 mL/min/1.73 m², the initial dose is 10 mg once daily.
    • Initiation is not recommended if eGFR is < 25 mL/min/1.73 m².
  • Administration: Take once daily by mouth with or without food, preferably at the same time each day. If unable to swallow whole, tablets can be crushed and mixed with water or soft food like applesauce.
  • Monitoring: Serum potassium and eGFR levels should be measured before initiation, 4 weeks after initiation or dose adjustment, and periodically thereafter. Do not initiate if serum potassium is > 5.0 mEq/L.

Side Effects

Common Side Effects:

  • High blood potassium levels (hyperkalemia).
  • Low blood pressure (hypotension).
  • Low blood sodium levels (hyponatremia).

Serious Side Effects:

  • Severe hyperkalemia, which can be life-threatening.
  • Allergic reactions (hives, difficulty breathing, swelling of face/lips/tongue/throat).

Precautions

  • Hyperkalemia: Regular monitoring of serum potassium is crucial, especially in patients with reduced kidney function or those taking other medications that increase potassium.
  • Drug Interactions:
    • Contraindicated with strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin, ketoconazole).
    • Avoid concomitant use with strong or moderate CYP3A4 inducers.
    • Avoid potassium-sparing diuretics (e.g., amiloride, spironolactone) and other mineralocorticoid receptor antagonists.
  • Grapefruit: Do not consume grapefruit or grapefruit juice, as it can increase finerenone levels and lead to more side effects.
  • Adrenal Insufficiency: Contraindicated in patients with adrenal insufficiency.
  • Liver Impairment: Avoid use in severe hepatic impairment; additional monitoring with moderate hepatic impairment.
  • Pregnancy and Breastfeeding: Not recommended during pregnancy unless clearly necessary. Avoid breastfeeding during treatment and for at least 1 day after the last dose. Women of childbearing potential should use effective contraception.

Storage

  • Store at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C to 30°C (59°F to 86°F).
  • Do not store above 30°C.
Frequently asked questions

KERENDIA (finerenone) 20 mg tablet is a medication used to treat chronic kidney disease (CKD) associated with type 2 diabetes (T2D). It helps reduce the risk of kidney disease progression, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure. KERENDIA is a product of Bayer Zydus Pharma Pvt. Ltd.

What is KERENDIA used for?

KERENDIA is prescribed for adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) to reduce the risk of sustained decline in kidney function, progression to end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction (heart attack), and hospitalization for heart failure. It can also reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure with left ventricular ejection fraction (HF LVEF) of ≥40%.

How does KERENDIA work?

KERENDIA contains the active substance finerenone, which is a nonsteroidal, selective antagonist of the mineralocorticoid receptor (MR). The MR is activated by hormones like aldosterone and cortisol and plays a role in regulating gene transcription, sodium reabsorption, and potassium excretion. Overactivation of the MR is believed to contribute to inflammation and fibrosis in the kidneys and heart. Finerenone works by blocking MR overactivation, thereby reducing inflammation and fibrosis, which helps protect the kidneys and heart.

What is the usual dosage of KERENDIA?

The typical starting dose of KERENDIA is 10 mg or 20 mg once daily, taken orally. The maintenance dose for many individuals is 20 mg once daily. Your doctor will determine your starting dose based on your kidney function (eGFR) and will monitor your blood potassium levels and kidney function regularly to adjust the dose as needed. You can take KERENDIA with or without food. If you are unable to swallow the tablet whole, it can be crushed and mixed with water or soft foods like applesauce and consumed immediately.

What are the possible side effects of KERENDIA?

Common side effects of KERENDIA include high potassium levels (hyperkalemia), low blood pressure (hypotension), and low sodium levels (hyponatremia). Other possible side effects include high uric acid levels and changes in kidney function test results. Serious side effects like chest pain, fainting, and hallucinations are less common. Your healthcare provider will monitor your blood work, blood pressure, and kidney function to manage any potential side effects.

Is KERENDIA safe during pregnancy or breastfeeding?

Pregnancy: There is no adequate data on the use of finerenone during human pregnancy to inform a drug-associated risk. Animal studies have shown developmental toxicity, including reduced fetal weight and impaired ossification, at higher exposures. Therefore, KERENDIA should generally not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. Patients of childbearing potential should use effective contraception during therapy.

Breastfeeding: Breastfeeding is not recommended while taking KERENDIA and for at least one day after the last dose. It is not known if KERENDIA passes into human breast milk or what effects it may have on a breastfed infant.

Can KERENDIA be taken with other medications?

KERENDIA can interact with several medications, supplements, and foods.

  • Strong CYP3A4 Inhibitors: Concomitant use with strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin, ketoconazole, ritonavir) is contraindicated as it significantly increases finerenone exposure and the risk of adverse reactions.
  • Moderate or Weak CYP3A4 Inhibitors: Monitor serum potassium during initiation or dosage adjustment of either KERENDIA or these inhibitors, and adjust the KERENDIA dosage as appropriate.
  • Strong or Moderate CYP3A4 Inducers: Avoid concomitant use as they can significantly decrease finerenone exposure, reducing its effectiveness.
  • Drugs that increase potassium levels: Medications like amiloride, triamterene, eplerenone, spironolactone, ACE inhibitors (e.g., enalapril, lisinopril), ARBs (e.g., losartan, valsartan), trimethoprim, and potassium supplements can increase the risk of hyperkalemia when taken with KERENDIA. Your doctor will monitor your potassium levels more frequently if you are taking these medications.
  • Grapefruit or Grapefruit Juice: Avoid consuming grapefruit or grapefruit juice while taking KERENDIA, as it can dangerously increase the blood levels of finerenone.

Always inform your healthcare provider about all prescription and over-the-counter medicines, vitamins, herbal products, and supplements you are taking.

What precautions should be taken with KERENDIA?

Before taking KERENDIA, discuss your health history with your doctor. Precautions include:

  • Hyperkalemia: KERENDIA can cause high potassium levels, which can be serious. Your doctor will check your potassium levels before and during treatment.
  • Severe Kidney Problems: KERENDIA is for CKD associated with type 2 diabetes. If you have other severe kidney problems or an eGFR less than 25 mL/min/1.73 m², initiation of treatment is not recommended due to limited clinical data.
  • Adrenal Insufficiency: KERENDIA should not be used if you have adrenal insufficiency.
  • Severe Liver Problems: KERENDIA should not be initiated in patients with severe hepatic impairment (Child-Pugh C). For moderate hepatic impairment (Child-Pugh B), additional serum potassium monitoring may be considered.
  • Blood Pressure: KERENDIA can cause a small decrease in blood pressure. Your doctor will monitor your blood pressure.

What happens if a dose is missed?

If you miss a dose of KERENDIA, take the missed dose as soon as you remember, but only on the same day. If you do not remember until the next day, skip the missed dose and continue with your regular schedule. Do not take two doses to make up for a missed dose.

How should KERENDIA be stored?

KERENDIA tablets should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F), with excursions permitted from 15°C to 30°C (59°F to 86°F). Do not store above 30°C. Keep the medicine out of the reach of children.